Global Infectious Disease Diagnostic Market
The Global Infectious Disease Diagnostics Market size is projected to reach USD 39.8 billion by 2027 from USD 28.1 billion in 2020, at a CAGR of 7.2%.
Infectious disease diagnosis is a diagnostic procedure that uses a variety of diagnostic tools to detect the presence of foreign antigens or organisms, and it is carried out by trained technicians or physicians. Various diagnosis procedures and instruments are used to analyse a sample of blood, urine, mucus, or other body fluids in order to provide information about the causative organism.
Drivers: The rising prevalence of infectious diseases, as well as a better understanding of diagnosis in developed economies, are major factors driving the infectious disease diagnostics market forward. Furthermore, rising healthcare costs, as well as the increasing adoption of technologically advanced diagnostic equipment in healthcare organisations, all contribute to the market's overall growth.
Restraints: In developed economies and some emerging economies, the lack of adequate reimbursement mechanisms obstructs market growth.
Impact of Covid-19
The COVID-19 outbreak is expected to have a positive effect on the global infectious disease diagnostic market's growth. With the COVID-19 pandemic, dealing with infectious disease has become a major medical concern around the world. Apart from vaccines and therapeutic drugs, there is a growing demand for more precise and simple testing technologies, as well as the expansion of testing structures. The COVID-19 pandemic has put a strain on global healthcare systems, necessitating the development of diagnostic instruments and diagnostic service centres. The demand for real-time polymerase chain reaction (RT-PCR) tests to detect COVID-19 has increased as the number of COVID-19 cases has increased.
Segmentation By Product: Global Infectious Disease Diagnostic Market is classified on the basis of Product into Reagents, Kits, and Consumables, Instruments, and Software & Services.
Segmentation By Technology: Global Infectious Disease Diagnostic Market is classified on the basis of Technology into Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other technologies.
Segmentation By Disease Type: Global Infectious Disease Diagnostic Market is classified on the basis of Disease Type into COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, and Other Infectious Diseases.
Segmentation By End User: Global Infectious Disease Diagnostic Market is classified on the basis of End User into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users.
Segmentation by Region: Global Infectious Disease Diagnostic Market is classified on the basis of Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape: The key players of Global Infectious Disease Diagnostic Market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), and PerkinElmer Inc. (US).
Industrial Developments
Market Taxonomy
By Product
By Technology
By Disease Type
By End User
By Region
Key Questions Addressed by the Report
Global Infectious Disease Diagnostic Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Infectious Disease Diagnostic Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5. Global Infectious Disease Diagnostic Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Infectious Disease Diagnostic Market Share Analysis, By Product
5.3 Infectious Disease Diagnostic Market Size and Forecast, By Product
5.3.1 Reagents, Kits, and Consumables
5.3.2 Instruments
5.3.3 Software & Services
6. Global Infectious Disease Diagnostic Market, By Technology
6.1 Y-o-Y Growth Comparison, By Technology
6.2 Infectious Disease Diagnostic Market Share Analysis, By Technology
6.3 Infectious Disease Diagnostic Market Size and Forecast, By Technology
6.3.1 Immunodiagnostics
6.3.2 Clinical Microbiology
6.3.3 PCR
6.3.4 INAAT
6.3.5 DNA Sequencing & NGS
6.3.6 DNA Microarrays
6.3.7 Other technologies
7. Global Infectious Disease Diagnostic Market, By Disease Type
7.1 Y-o-Y Growth Comparison, By Disease Type
7.2 Infectious Disease Diagnostic Market Share Analysis, By Disease Type
7.3 Infectious Disease Diagnostic Market Size and Forecast, By Disease Type
7.3.1 COVID-19
7.3.2 HIV
7.3.3 HAIs
7.3.4 Hepatitis
7.3.5 CT/NG
7.3.6 HPV
7.3.7 TB
7.3.8 Influenza
7.3.9 Other Infectious Diseases
8. Global Infectious Disease Diagnostic Market, By End User
8.1 Y-o-Y Growth Comparison, By End User
8. Infectious Disease Diagnostic Market Share Analysis, By End User
8.3 Infectious Disease Diagnostic Market Size and Forecast, By End User
8.3.1 Diagnostic Laboratories
8.3.2 Hospitals & Clinics
8.3.3 Academic Research Institutes
8.3.4 Other End Users
9. Global Infectious Disease Diagnostic Market, By Region
9.1 Infectious Disease Diagnostic Market Share Analysis, By Region
9.2 Infectious Disease Diagnostic Market Size and Forecast, By Region
9.3 Infectious Disease Diagnostic Market Size and Forecast, By Region
10. North America Infectious Disease Diagnostic Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 North America Infectious Disease Diagnostic Market Share Analysis, By Product
10.3 North America Infectious Disease Diagnostic Market Size and Forecast, By Technology
10.4 North America Infectious Disease Diagnostic Market Size and Forecast, By Disease Type
10.5 North America Infectious Disease Diagnostic Market Size and Forecast, By End User
10.6 North America Infectious Disease Diagnostic Market Size and Forecast, By Geography
10.6.1 US
10.6.2 Canada
11. Europe Infectious Disease Diagnostic Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Europe Infectious Disease Diagnostic Market Share Analysis, By Product
11.3 Europe Infectious Disease Diagnostic Market Size and Forecast, By Technology
11.4 Europe Infectious Disease Diagnostic Market Size and Forecast, By Disease Type
11.5 Europe Infectious Disease Diagnostic Market Size and Forecast, By End User
11.6 Europe Infectious Disease Diagnostic Market Size and Forecast, By Country
11.6.1 UK
11.6.2 Germany
11.6.3 France
11.6.4 Italy
11.6.5 Spain
11.6.6 Netherland
12. Asia Pacific Infectious Disease Diagnostic Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Asia Pacific Infectious Disease Diagnostic Market Share Analysis, By Product
12.3 Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, By Technology
12.4 Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, By Disease Type
12.5 Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, By End User
12.6 Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4 Australia
13. Latin America Infectious Disease Diagnostic Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Latin America Infectious Disease Diagnostic Market Share Analysis, By Product
13.3 Latin America Infectious Disease Diagnostic Market Size and Forecast, By Technology
13.4 Latin America Infectious Disease Diagnostic Market Size and Forecast, By Disease Type
13.5 Latin America Infectious Disease Diagnostic Market Size and Forecast, By End User
13.6 Latin America Infectious Disease Diagnostic Market Size and Forecast, By Country
13.6.1 Brazil
13.6.2 Rest of Latin America
14 Middle East Infectious Disease Diagnostic Market Analysis and Forecast (2021-2027)
14.1 Introduction
14.2 Middle East Infectious Disease Diagnostic Market Share Analysis, By Product
14.3 Middle East Infectious Disease Diagnostic Market Size and Forecast, By Technology
14.4 Middle East Infectious Disease Diagnostic Market Size and Forecast, By Disease Type
14.5 Middle East Infectious Disease Diagnostic Market Size and Forecast, By End User
14.6 Middle East Infectious Disease Diagnostic Market Size and Forecast, By Country
14.6.1 Saudi Arabia
14.6.2 UAE
14.6.3. Egypt
14.6.4. Kuwait
14.6.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16. Company Profiles
16.1 Abbott Laboratories (US)
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 F. Hoffmann-La Roche Ltd(Switzerland)
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 bioMérieux SA (France)
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Danaher Corporation (US)
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Sysmex Corporation (Japan)
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategie
16.6 Becton, Dickinson and Company (US)
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Bio-Rad Laboratories, Inc. (US)
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
